Cargando…
SGLT2 inhibition attenuates arterial dysfunction and decreases vascular F-actin content and expression of proteins associated with oxidative stress in aged mice
Aging of the vasculature is characterized by endothelial dysfunction and arterial stiffening, two key events in the pathogenesis of cardiovascular disease (CVD). Treatment with sodium glucose transporter 2 (SGLT2) inhibitors is now known to decrease cardiovascular morbidity and mortality in type 2 d...
Autores principales: | Soares, Rogerio N., Ramirez-Perez, Francisco I., Cabral-Amador, Francisco J., Morales-Quinones, Mariana, Foote, Christopher A., Ghiarone, Thaysa, Sharma, Neekun, Power, Gavin, Smith, James A., Rector, R. Scott, Martinez-Lemus, Luis A., Padilla, Jaume, Manrique-Acevedo, Camila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213629/ https://www.ncbi.nlm.nih.gov/pubmed/35426600 http://dx.doi.org/10.1007/s11357-022-00563-x |
Ejemplares similares
-
OR17-06 Transglutaminase 2 Inhibition Reduces Aortic Stiffness in Western Diet-Fed Female Mice
por: Chinnakotla, Bhavana, et al.
Publicado: (2020) -
Mineralocorticoid Receptor in Myeloid Cells Mediates Angiotensin II-Induced Vascular Dysfunction in Female Mice
por: Manrique-Acevedo, Camila, et al.
Publicado: (2021) -
Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury
por: Aroor, Annayya R., et al.
Publicado: (2018) -
Effects of Physical Exercise on the Stereotyped Behavior of Children with Autism Spectrum Disorders
por: Ferreira, José Pedro, et al.
Publicado: (2019) -
GEDAE-LaB: A Free Software to Calculate the Energy System Contributions during Exercise
por: Bertuzzi, Rômulo, et al.
Publicado: (2016)